Clinical Endocrinology News Digital Network BARCELONA – Treatment of type 2 diabetes with a sulfonylurea drug was tied to a significantly increased risk of death in two large U.K. epidemiology studies with a total of more than 100,000 patients. These and other recent findings that raised ...
Family Practice News Digital Network BARCELONA – Treatment of type 2 diabetes with a sulfonylurea drug was tied to a significantly increased risk of death in two large U.K. epidemiology studies with a total of more than 100,000 patients. These and other recent findings that raised ... and more »
PharmaTimes A subgroup analysis comparing DPP-4 to sulfonylurea showed a similarly protective effect of DPP-4 on autoimmune diseases, but not comparing the drugs versu...
Science Daily (press release) Subgroup analysis comparing DPP4i to sulfonylurea showed similarly protective effect of DPP4i on autoimmune diseases, but not comparing DPP4i versus thiazolidinediones. "Among patients with type 2 diabetes, initiating DPP4i combination therapy may be ... and more »
Zacks.com Merck is working on penetrating the sulfonylurea class. One of the factors adversely impacting revenues could be Increased rebate and pricing pressure as competitors are working on improving their formulary positions by increasing discounts. Gardasil ... and more »
Healio According to Rury R. Holman, FRCP, director of the University of Oxford Diabetes Trials Unit and honorary consultant physician to the Oxford Radcliffe Hospitals NHS Trust, the effect of the early addition of metformin to sulfonylurea does not appear to ... and more »
Newswise (press release) Subgroup analysis comparing DPP4i to sulfonylurea showed similarly protective effect of DPP4i on autoimmune diseases, but not comparing DPP4i versus thiazolidinediones. “Among patients with type 2 diabetes, initiating DPP4i combination therapy may be ... and more »
Clinical Endocrinology News Digital Network Patients in the groundbreaking U.K. Prospective Diabetes Study (UKPDS) who took the drug along with a sulfonylurea don't appear to have any long-term increases in the risk of diabetes-related death, all-cause mortality, or cardiovascular events, Dr ... and more »
Healio According to Rury R. Holman, FRCP, director of the University of Oxford Diabetes Trials Unit and honorary consultant physician to the Oxford Radcliffe Hospitals NHS Trust, the effect of the early addition of metformin to sulfonylurea does not appear to ... and more »
Family Practice News Digital Network Patients in the groundbreaking U.K. Prospective Diabetes Study (UKPDS) who took the drug along with a sulfonylurea don't appear to...
